HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oxidation of remnant-like particles from serum of diabetic patients, patients with ischemic heart disease and normal subjects.

Abstract
Remnant-like particles (RLP) are reportedly involved in the pathogenesis of atherosclerosis, as are lipid peroxides. To assess the role of the oxidation of RLP in this disease, we compared the oxidation of RLP with that of total very low density lipoproteins (VLDL) obtained from the serum of 10 patients with ischemic heart disease (IHD), 10 patients with diabetes mellitus (DM) and 10 normal subjects by measuring the levels of thiobarbituric acid reactive substances (TBARS). Our results indicated that RLP were oxidized in vivo to a greater extent than total VLDL in all three groups of subjects. The serum levels of RLP were significantly higher in the patients than in the normal subjects. The oxidation of RLP may therefore be involved in the progression of atherosclerosis in patients with IHD or DM.
AuthorsM Tamura, A Tanaka, K Yui, K Nakajima, F Numano
JournalHormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme (Horm Metab Res) Vol. 29 Issue 8 Pg. 398-402 (Aug 1997) ISSN: 0018-5043 [Print] Germany
PMID9288578 (Publication Type: Journal Article)
Chemical References
  • Chylomicrons
  • Lipid Peroxides
  • Lipoproteins, VLDL
  • Thiobarbituric Acid Reactive Substances
Topics
  • Adult
  • Aged
  • Chylomicrons (blood)
  • Coronary Artery Disease (blood, diagnosis)
  • Coronary Disease (blood, diagnosis)
  • Diabetes Mellitus (blood, diagnosis)
  • Female
  • Humans
  • Lipid Peroxides (blood)
  • Lipoproteins, VLDL (blood)
  • Male
  • Middle Aged
  • Oxidation-Reduction
  • Reference Values
  • Thiobarbituric Acid Reactive Substances (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: